Wells Fargo & Company Kamada LTD Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Kamada LTD stock. As of the latest transaction made, Wells Fargo & Company holds 630,688 shares of KMDA stock, worth $4.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
630,688
Previous 629,884 0.13%
Holding current value
$4.96 Million
Previous $3.38 Million 13.54%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$5.17 - $6.27 $4,156 - $5,041
804 Added 0.13%
630,688 $3.84 Million
Q3 2024

Nov 13, 2024
SELL
$4.83 - $6.25 $38,041 - $49,225
-7,876 Reduced 1.23%
629,884 $3.38 Million
Q2 2024

Aug 13, 2024
BUY
$4.78 - $5.75 $62,106 - $74,709
12,993 Added 2.08%
637,760 $3.16 Million
Q1 2024

May 10, 2024
SELL
$5.58 - $6.42 $132,519 - $152,468
-23,749 Reduced 3.66%
624,767 $3.5 Million
Q4 2023

Feb 09, 2024
SELL
$4.14 - $6.22 $4,554 - $6,842
-1,100 Reduced 0.17%
648,516 $3.97 Million
Q3 2023

Nov 13, 2023
BUY
$4.86 - $5.83 $20,402 - $24,474
4,198 Added 0.65%
649,616 $3.47 Million
Q2 2023

Aug 15, 2023
BUY
$4.48 - $5.53 $33,008 - $40,745
7,368 Added 1.15%
645,418 $3.41 Million
Q1 2023

May 12, 2023
BUY
$4.12 - $5.25 $511,596 - $651,913
124,174 Added 24.16%
638,050 $2.96 Million
Q4 2022

Feb 13, 2023
BUY
$3.79 - $4.84 $83,429 - $106,542
22,013 Added 4.48%
513,876 $2.06 Million
Q3 2022

Nov 14, 2022
BUY
$4.42 - $5.43 $221,760 - $272,433
50,172 Added 11.36%
491,863 $2.18 Million
Q2 2022

Aug 12, 2022
BUY
$4.22 - $5.85 $21,197 - $29,384
5,023 Added 1.15%
441,691 $2.03 Million
Q1 2022

May 16, 2022
SELL
$5.43 - $6.81 $94,856 - $118,963
-17,469 Reduced 3.85%
436,668 $2.41 Million
Q4 2021

Feb 14, 2022
BUY
$5.21 - $6.82 $35,579 - $46,573
6,829 Added 1.53%
454,137 $2.99 Million
Q3 2021

Nov 15, 2021
BUY
$5.25 - $5.87 $977,576 - $1.09 Million
186,205 Added 71.31%
447,308 $2.37 Million
Q2 2021

Aug 16, 2021
BUY
$5.67 - $6.33 $56 - $63
10 Added 0.0%
261,103 $1.52 Million
Q1 2021

May 13, 2021
BUY
$6.02 - $8.06 $723,929 - $969,247
120,254 Added 85.38%
261,093 $1.62 Million
Q4 2020

Feb 09, 2021
BUY
$6.3 - $8.46 $886,668 - $1.19 Million
140,741 Added 143613.27%
140,839 $913,000
Q3 2020

Nov 05, 2020
SELL
$8.02 - $11.73 $3,224 - $4,715
-402 Reduced 80.4%
98 $1,000
Q2 2020

Aug 13, 2020
BUY
$5.37 - $9.45 $2,685 - $4,725
500 New
500 $4,000

Others Institutions Holding KMDA

# of Institutions
31
Shares Held
6.21M
Call Options Held
200
Put Options Held
0
View Full List

About KAMADA LTD

KMDA Quotes by TradingView
  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $352M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email